Related Experiment Videos
The effect of nimesulide on prostanoid formation
1Department of Scientific Affairs, Helsinn Healthcare, Chiasso, Switzerland.
Drugs
|January 1, 1993
Summary
Nimesulide, a novel nonsteroidal anti-inflammatory drug (NSAID), demonstrates potent anti-inflammatory and analgesic effects by inhibiting prostaglandin synthesis. This sulfonanilide derivative does not induce gastrointestinal lesions or affect renal function in animal models.
Area of Science:
- Pharmacology
- Medicinal Chemistry
Background:
- Nimesulide is a weak acidic (pKa = 6.50) nonsteroidal anti-inflammatory drug (NSAID) belonging to the sulfonanilide chemical class.
- Unlike other NSAIDs, it lacks a carboxylic group.
Purpose of the Study:
- To characterize the pharmacological activities of nimesulide.
- To investigate its mechanism of action and safety profile.
Main Methods:
- Evaluation of anti-inflammatory, analgesic, and antipyretic activities in animal models.
- Assessment of cyclo-oxygenase inhibition in specific tissues.
- Investigation of prostaglandin and thromboxane B2 synthesis inhibition.
- Analysis of gastrointestinal and renal effects in animal models.
Main Results:
- Nimesulide exhibits potent anti-inflammatory, analgesic, and antipyretic activities.
- It inhibits prostaglandin synthesis in zymosan-stimulated murine macrophages and antagonizes thromboxane B2 formation in lung tissue.
- Nimesulide does not inhibit cyclo-oxygenase in gastric tissues or bovine seminal vesicle microsomes.
- No gastrointestinal lesions or adverse effects on renal function were observed in animal models.
Conclusions:
- Nimesulide possesses significant anti-inflammatory and analgesic properties through mechanisms independent of direct cyclo-oxygenase inhibition in certain tissues.
- Its favorable gastrointestinal and renal safety profile in animal models suggests potential therapeutic advantages.